NASP expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.55111512312578E-16 |
Normal-vs-Stage2 |
2.436400E-04 |
Normal-vs-Stage3 |
2.528700027149E-09 |
Normal-vs-Stage4 |
9.35150001879492E-09 |
Stage1-vs-Stage2 |
6.096400E-01 |
Stage1-vs-Stage3 |
6.624200E-01 |
Stage1-vs-Stage4 |
9.480000E-01 |
Stage2-vs-Stage3 |
8.215600E-01 |
Stage2-vs-Stage4 |
6.114200E-01 |
Stage3-vs-Stage4 |
7.080200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
3.21399999947403E-07 |
Normal-vs-Asian |
1.60439999999928E-05 |
Caucasian-vs-AfricanAmerican |
1.302200E-01 |
Caucasian-vs-Asian |
4.317400E-01 |
AfricanAmerican-vs-Asian |
8.884400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.6796564139554E-12 |
Normal-vs-Female |
1.62447832963153E-12 |
Male-vs-Female |
7.760300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.197700E-04 |
Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
Normal-vs-Age(61-80Yrs) |
2.52831089397887E-12 |
Normal-vs-Age(81-100Yrs) |
2.374100E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.978200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.842000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.451400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.725900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.232200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.518800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.54289999998447E-06 |
Normal-vs-Grade 2 |
1.11022302462516E-16 |
Normal-vs-Grade 3 |
4.3754999623502E-10 |
Normal-vs-Grade 4 |
2.49969999999156E-06 |
Grade 1-vs-Grade 2 |
6.386400E-04 |
Grade 1-vs-Grade 3 |
2.1886000000082E-06 |
Grade 1-vs-Grade 4 |
2.435900E-04 |
Grade 2-vs-Grade 3 |
5.219300E-03 |
Grade 2-vs-Grade 4 |
1.556560E-01 |
Grade 3-vs-Grade 4 |
5.872800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
1.11540000002908E-06 |
ccA subtype-vs-ccB subtype |
4.23010000000223E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.47390996577224E-12 |
Normal-vs-N1 |
5.360400E-02 |
N0-vs-N1 |
4.100000E-01 |
|
|